Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$462K Buy
19,182
+3,276
+21% +$85.7K 0.25% 90
2026
Q1
$447K Hold
15,906
0.27% 91
2025
Q4
$396K Hold
15,906
0.24% 97
2025
Q3
$405K Hold
15,906
0.26% 91
2025
Q2
$386K Buy
15,906
+107
+0.7% +$2.5K 0.26% 94
2025
Q1
$400K Sell
15,799
-774
-5% -$20.3K 0.27% 88
2024
Q4
$440K Hold
16,573
0.29% 86
2024
Q3
$480K Hold
16,573
0.34% 84
2024
Q2
$464K Sell
16,573
-745
-4% -$20.5K 0.36% 78
2024
Q1
$481K Sell
17,318
-643
-4% -$17.8K 0.35% 80
2023
Q4
$517K Hold
17,961
0.46% 67
2023
Q3
$596K Buy
17,961
+543
+3% +$19.2K 0.57% 49
2023
Q2
$639K Buy
17,418
+195
+1% +$7.59K 0.59% 47
2023
Q1
$703K Sell
17,223
-200
-1% -$8.64K 0.66% 44
2022
Q4
$893K Hold
17,423
0.85% 35
2022
Q3
$762K Sell
17,423
-145
-0.8% -$7.05K 0.82% 35
2022
Q2
$921K Buy
17,568
+190
+1% +$9.68K 0.95% 31
2022
Q1
$900K Sell
17,378
-600
-3% -$31.1K 0.82% 38
2021
Q4
$1.06M Buy
+17,978
New +$891K 0.95% 29
2019
Q4
$820K Buy
+22,056
New +$786K 0.81% 37

Other funds holding PFE

TI-Trust's PFE Position: Q2 2026 in Review

TI-Trust increased its Pfizer (PFE) stake by 21% in Q2 2026, buying an estimated $85.7K and bringing the position to 19,182 shares worth $462K. The position accounts for 0.25% of the portfolio, ranked #90.

TI-Trust first reported a position in PFE in Q4 2019 and has held it in 20 quarters since. The position peaked at $1.06M in Q4 2021. 1,179 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • TI-Trust held 19,182 shares of Pfizer worth $462K as of Q2 2026.
  • TI-Trust bought 3,276 Pfizer shares in Q2 2026, an estimated $85.7K.
  • Pfizer made up 0.25% of TI-Trust's portfolio in Q2 2026, its #90 holding.
  • TI-Trust first reported a position in Pfizer in Q4 2019 and has held it in 20 quarters since.
  • TI-Trust's Pfizer position peaked at $1.06M in Q4 2021.
  • 1,179 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on TI-Trust's 13F filing for Q2 2026, filed 23 Jul 2026.